Esra AKAY, Ömer ŞENORMANCI, Rıza ERÖKSÜZ, Güliz ŞENORMANCI, Onur Okan Demirci

The effect of psychopathology on quality of life and disability in patients with fibromyalgia

Objectives: The aim of the study was to investigate the relationship between pain, depression, anxiety, somatic amplification and alexithymia in patients with fibromyalgia syndrome (FMS), and on quality of life and disability. As a secondary goal, the predictors of disability were evaluated. Methods: Participants were 112 female patients aged 18 and over, applied to the outpatient clinic of University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital Medical Ecology and Hydroclimatology department and diagnosed with FMS according to ACR 2016 Revised Fibromyalgia Diagnosis Criteria. The Sociodemographic Data Form, Visual Analog Scale (VAS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Toronto Alexithymia Scale (TAS-20), Somatosensory Amplification Scale (SSAS), Fibromyalgia Impact Questionnaire (FIQ) and Health Survey Questionnaire Short Form (SF-36) were applied to each participant. All data were analyzed with correlation and linear regression. Results: Increased pain intensity, depression, anxiety, somatic amplification, "difficulty identifying feeling" and "difficulty describing feelings" dimensions of alexithymia were found related to lower quality of life and increased disability. Depression, somatic amplification, and pain severity were defined as the predictors of disability in FMS. Conclusions: Psychiatric examination of FMS patients especially in terms of depression, anxiety, alexithymia and somatic amplification as well as their physical complaints can be beneficial to minimize disability and increase the quality of life. To our best knowledge, this is the first study to show somatic amplification as a predictor of disability in FMS patients. Further studies will be helpful to understand this relationship.

Keywords:

Alexithymia anxiety, depression, fibromyalgia syndrome, quality of life, somatization,

PDF

___

1. Sivas FA, Başkan BM, Aktekin LA, Çınar NK, Yurdakul FG, Özoran K. [Assessment of depression, sleep disorders and quality of life in patients with fibromyalgia]. Turk J Phys Med Rehab 2009;55:8-12. [Article in Turkish]
2. Özcan DS, Aras M, Köseoğlu BF, Güven ŞŞ. [Quality of life and associated conditions in women with fibromyalgia syndrome]. Turk J Osteoporos 2013;19:42-7. [Article in Turkish]
3. González E, Elorza J, Failde I. Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients. Actas Esp Psiquiatr 2010;38:295-300.
4. Madenci E, Herken H, Yağız E, Keven S, Gürsoy S. [Depression levels and the ways of coping with pain in patients with chronic pain and fibromyalgia syndromes]. Turk J Phys Med Rehabil 2006;52:19-21. [Article in Turkish]
5. Martinez JE, Casagrande P, Ferreira PP, Rossatto BL. Correlation between demographic and clinical variables and fibromyalgia severity. Rev Bras Reumatol 2013;53:460-3.
6. McDowell CP, Cook DB, Herring MP. The effects of exercise training on anxiety in fibromyalgia patients: a meta-analysis. Med Sci Sports Exerc 2017;49:1868-76.
7. Taylor GJ, Parker JD, Bagby RM, Acklin MW. Alexithymia and somatic complaints in psychiatric out-patients. J Psychosom Res 1992;36:417-24.
8. Taylor GJ. Alexithymia: concept, measurement, and implications for treatment. Am J Psychiatry 1984;141:725-32.
9. Lumley MA, Stettner L, Wehmer F. How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996;41:505-18.
10. Hosoi M, Molton IR, Jensen MP, Ehde DM, Amtmann S, O’Brien S, et al. Relationships among alexithymia and pain intensity, pain interference, and vitality in persons with neuromuscular disease: considering the effect of negative affectivity. Pain 2010;149:273-7.
11. Lipowski ZJ. Somatization: a borderland between medicine and psychiatry. CMAJ 1986;135:609-14.
12. Burke ALJ, Mathias JL, Denson LA. Psychological functioning of people living with chronic pain: a meta-analytic review. Br J Clin Psychol 2015;5:345-60.
13. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46:319-29.
14. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
16. Hisli N. [Reability and validity of Beck Depression Inventory among university students]. J Turk Psychol 1989;7:3-13. [Article in Turkish]
17. Beck AT, Epstein N, Brown G, Steer RA. An invention for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-7.
18. Ulusoy M, Erkmen H, Şahin N. Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cog Psychother 1998;12:163-72.
19. Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I Item selection and cross validation of the factor structure. J Psychosom Res 1994;38:23-32.
20. Güleç H, Köse S, Güleç MY, Çitak S, Evren C, Borckardt J, et al. Reliability and factorial validity of the Turkish version of the 20-Item Toronto alexithymia scale (TAS-20). Bull Clin Psychopharmacol 2009;19:214-20.
21. Barsky AJ, Wyshak G, Klerman GL. The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 1990;24:323-34.
22. Güleç H, Sayar K, Yazici M. [The reliability and validity of the Turkish form of the somatosensory amplification scale]. Düşünen Adam 2007;20:16-24. [Article in Turkish]
23. Ware J, Sherbourne C. The MOS 36-item shortform health survey (Sf-36): I. conceptual framework and item selection. Med Care 1992;30:473-83.
24. Koçyiğit H, Aydemir Ö, Fişek G, Memiş A. [Reliability and validity of the Turkish version of Short form-36]. İlaç ve Tedavi Dergisi 1999;12:102-6. [Article in Turkish]
25. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-33.
26. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12.
27. Turk DC, Robinson JP, Burwinkle T. Prevalence of fear of pain and activity in patients with fibromyalgia syndrome. J Pain 2004;5:483-90.
28. Campos RP, Vázquez Rodríguez MI. Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated. Clin Rheumatol 2012;31:347-55.
29. Işık Ulusoy S. Evaluation of affective temperament and anxiety-depression levels in fibromyalgia patients: a pilot study. Braz J Psychiatry 2019;41:428-32.
30. Liao SC, Ma HM, Lin YL, Huang WL. Functioning and quality of life in patients with somatic symptom disorder: The association with comorbid depression. Compr Psychiatry 2019;90:88-94.
31. Singh G, Kaul S. Anxiety and depression are common in fibromyalgia patients and correlate with symptom severity score. Indian J Rheumatol 2018;13:168.
32. Fernandez E. Anxiety, depression, and anger in pain. Dallas: Advanced Psychological Resources, Inc; 2002.
33. Fujii T, Oka H, Katsuhira J, Tonosu J, Kasahara S, Tanaka S, et al. Association between somatic symptom burden and health-related quality of life in people with chronic low back pain. PLoS One 2018;13:e0193208.
34. Güçlü DG, Güçlü O, Ozaner A, Şenormancı Ö, Konkan R. The relationship between disability, quality of life and fear- avoidance beliefs in patients with chronic low back pain. Turk Neurosurg 2012;22:724-31.
35. Güçlü DG, Senormancı Ö, Güçlü O, Çırak M, Konkan R, Erkıran M. [The effect of psychopathology on quality of life and disability of patients with chronic neck pain]. Turkiye Klinikleri J Med Sci 2013;33:702-10. [Article in Turkish]
36. Ailliet L, Rubinstein SM, Knol D, van Tulder MW, de Vet HC. Somatization is associated with worse outcome in a chiropractic patient population with neck pain and low back pain. Man Ther 2016;21:170-6.
37. Shim EJ, Park A, Park SP. The relationship between alexithymia and headache impact: the role of somatization and pain catastrophizing. Qual Life Res 2018;27:2283-94.
38. Tesio V, Di Tella M, Ghiggia A, Romeo A, Colonna F, Fusaro E, et al. Alexithymia and depression affect quality of life in patients with chronic pain: A study on 205 patients with fibromyalgia. Front Psychol 2018;9:442.
39. Taycan O, Özdemir A, Erdoğan Taycan S. Alexithymia and somatization in depressed patients: the role of the type of somatic symptom attribution. Noro Psikiyatr Ars 2017;54:99-104.